Please use this identifier to cite or link to this item:
|Title:||Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial|
|Author:||Chiva Blanch, Gemma|
Urpí Sardà, Mireia
Rotchés Ribalta, Maria
Arranz Martínez, Sara
Valderas Martínez, Palmira
Corella Piquer, Dolores
Tinahones, Francisco J.
Lamuela Raventós, Rosa Ma.
Andrés Lacueva, Ma. Cristina
Estruch Riba, Ramon
|Publisher:||American Society for Nutrition|
|Abstract:||Background: Few clinical studies have focused on the alcoholindependent cardiovascular effects of the phenolic compounds of red wine (RW). Objective: We aimed to evaluate the effects of ethanol and phenolic compounds of RW on the expression of inflammatory biomarkers related to atherosclerosis in subjects at high risk of cardiovascular disease. Design: Sixty-seven high-risk, male volunteers were included in a randomized, crossover consumption trial. After a washout period, all subjects received RW (30 g alcohol/d), the equivalent amount of dealcoholized red wine (DRW), or gin (30 g alcohol/d) for 4 wk. Before and after each intervention period, 7 cellular and 18 serum inflammatory biomarkers were evaluated. Results: Alcohol increased IL-10 and decreased macrophage-derived chemokine concentrations, whereas the phenolic compounds of RW decreased serum concentrations of intercellular adhesion molecule- 1, E-selectin, and IL-6 and inhibited the expression of lymphocyte function-associated antigen 1 in T lymphocytes and macrophage-1 receptor, Sialil-Lewis X, and C-C chemokine receptor type 2 expression in monocytes. Both ethanol and phenolic compounds of RW downregulated serum concentrations of CD40 antigen, CD40 ligand, IL-16, monocyte chemotactic protein-1, and vascular cell adhesion molecule-1. Conclusion: The results suggest that the phenolic content of RW may modulate leukocyte adhesion molecules, whereas both ethanol and polyphenols of RW may modulate soluble inflammatory mediators in high-risk patients. The trial was registered in the International Standard Randomized Controlled Trial Number Register at http://www. isrctn.org/ as ISRCTN88720134|
|It is part of:||American Journal of Clinical Nutrition, 2012, vol. 95, num. 2, p. 326-334|
|Appears in Collections:||Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)|
Articles publicats en revistes (Medicina)
Files in This Item:
|607285.pdf||170.83 kB||Adobe PDF||View/Open Request a copy|
Document embargat fins el 1-1-2099
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.